Company develops immunotherapies for cancer, inflammation, and autoimmunity disorders using protein design technology.
Neoleukins
Company develops immunotherapies for cancer, inflammation, and autoimmunity disorders using protein design technology.
Company develops immunotherapies for cancer, inflammation, and autoimmunity disorders using protein design technology.